Calysta, Inc. announced late January the completion of a Series B financing round totaling US $10 million. The financing was led by Aqua-Spark, a Netherlands-based firm that focusses on sustainable aquaculture companies and Walden Riverwood Ventures, a venture firm that invests in core technology companies globally.
Calysta intends to use the investment to advance development of high value nutritional products for fish and livestock as well as traditional chemical products.
“Calysta is committed to advancing the sustainability of the aquaculture industry, a critical contributor to global food security. This financing allows us to accelerate market introduction of our Microbial Protein™ Feed into this important market.” Alan Shaw, Ph.D., President and CEO stated in a company press release.
According to its website, Aqua-Spark launched in 2013 and has raised US$10m for investing in areas of the aquaculture industry that will make fish farming sustainable. The aim of the fund is to grow to US$400m by 2025. Its first round of investments is valued at US$4m.
Aqua-Spark, a global investment fund based in Utrecht, the Netherlands is investing in the US biotechnology company Calysta.